Xeber.world
Biogen’s experimental Alzheimer’s drug diranersen reduced tau levels in early-stage patients and slowed cognitive decline in a Phase 2 trial. Meanwhil...
Biogen announced mixed results from a Phase 2 Alzheimer’s trial testing diranersen (BIIB080), a tau-targeting therapy. The drug reduced tau levels in...
New research from Loma Linda University suggests regular egg consumption may significantly reduce Alzheimer's risk. Eating eggs five or more times per...
A physician reflects on the unique grief experienced by caregivers of dementia patients, highlighting the emotional toll of 'ambiguous loss' and the c...
Axsome Therapeutics has received FDA approval for its Alzheimer’s agitation drug, marking a significant advancement in neurotherapeutic treatments. Th...
A new study reveals that standard Alzheimer's cognitive screening tools may not accurately reflect brain changes in women compared to men. The finding...
Governments and industries are investing heavily in neuroscience to combat brain diseases and promote cognitive health. Yet mental illness remains sid...
New research reveals that the health of dementia caregivers is significantly shaped by their spousal relationship dynamics. The study found that emoti...